Advanced search
Publication Cover
Molecular and Cellular Biology Volume 23, 2003 - Issue 16
Submit an article Journal homepage
66
Views
169
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Silencing of the Novel p53 Target Gene Snk/Plk2 Leads to Mitotic Catastrophe in Paclitaxel (Taxol)-Exposed Cells

Timothy F. BurnsLaboratory of Molecular Oncology and Cell Cycle Regulation, Howard Hughes Medical Institute, Departments of Medicine, Genetics, and Pharmacology and Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania19104
,
Peiwen FeiLaboratory of Molecular Oncology and Cell Cycle Regulation, Howard Hughes Medical Institute, Departments of Medicine, Genetics, and Pharmacology and Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania19104
,
Kimberly A. ScataLaboratory of Molecular Oncology and Cell Cycle Regulation, Howard Hughes Medical Institute, Departments of Medicine, Genetics, and Pharmacology and Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania19104
,
David T. DickerLaboratory of Molecular Oncology and Cell Cycle Regulation, Howard Hughes Medical Institute, Departments of Medicine, Genetics, and Pharmacology and Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania19104
&
Wafik S. El-DeiryLaboratory of Molecular Oncology and Cell Cycle Regulation, Howard Hughes Medical Institute, Departments of Medicine, Genetics, and Pharmacology and Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania19104Correspondence[email protected]
Pages 5556-5571 | Received 11 Feb 2003, Accepted 22 May 2003, Published online: 27 Mar 2023

Citations (169)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Klaus Strebhardt, Sven Becker & Yves Matthess. (2015) Thoughts on the current assessment of Polo-like kinase inhibitor drug discovery. Expert Opinion on Drug Discovery 10:1, pages 1-8.
Read now
Martin Fischer, Lydia Steiner & Kurt Engeland. (2014) The transcription factor p53: Not a repressor, solely an activator. Cell Cycle 13:19, pages 3037-3058.
Read now
Sandra N Craig, Michael D Wyatt & Campbell McInnes. (2014) Current assessment of polo-like kinases as anti-tumor drug targets. Expert Opinion on Drug Discovery 9:7, pages 773-789.
Read now
Puneet Chopra, Gautam Sethi, Sunanda G Dastidar & Abhijit Ray. (2010) Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics. Expert Opinion on Investigational Drugs 19:1, pages 27-43.
Read now
Jung-Sik Kim, Carolyn Lee, Challice L. Bonifant, Habtom Ressom & Todd Waldman. (2007) Activation of p53-Dependent Growth Suppression in Human Cells by Mutations in PTEN or PIK3CA. Molecular and Cellular Biology 27:2, pages 662-677.
Read now
Bipin C. Dash & Wafik S. El-Deiry. (2005) Phosphorylation of p21 in G2/M Promotes Cyclin B-Cdc2 Kinase Activity. Molecular and Cellular Biology 25:8, pages 3364-3387.
Read now
Barbara C. M. van de Weerdt, Marcel A. T. M. van Vugt, Catherine Lindon, Jos J. W. Kauw, Marieke J. Rozendaal, Rob Klompmaker, Rob M. F. Wolthuis & René H. Medema. (2005) Uncoupling Anaphase-Promoting Complex/Cyclosome Activity from Spindle Assembly Checkpoint Control by Deregulating Polo-Like Kinase 1. Molecular and Cellular Biology 25:5, pages 2031-2044.
Read now
Margret B. Einarson, Edna Cukierman, Duane A. Compton & Erica A. Golemis. (2004) Human Enhancer of Invasion-Cluster, a Coiled-Coil Protein Required for Passage through Mitosis. Molecular and Cellular Biology 24:9, pages 3957-3971.
Read now

Articles from other publishers (161)

Da-Eun Kim, Hye Eun Byeon, Dae-Hoon Kim, Sang Geon Kim & Hyungshin Yim. (2022) Plk2-mediated phosphorylation and translocalization of Nrf2 activates anti-inflammation through p53/Plk2/p21cip1 signaling in acute kidney injury. Cell Biology and Toxicology 39:4, pages 1509-1529.
Crossref
Muhittin Akarsu, Güntülü Ak, Emine Dündar & Muzaffer Metintaş. (2023) Genetic analysis of familial predisposition in the pathogenesis of malignant pleural mesothelioma. Journal of Cancer Research and Clinical Oncology.
Crossref
Risa Yamaoka, Fumito Kanada, Masaya Nagaya, Masaru Takashima, Yoshihiro Takamura, Masaru Inatani & Masaya Oki. (2022) Analysis of cataract-regulated genes using chemical DNA damage induction in a rat ex vivo model. PLOS ONE 17:12, pages e0273456.
Crossref
Quan Li, Pan Zhang, Huixiao Hu, Hang Huang, Dong Pan, Guangyun Mao & Burong Hu. (2022) The DDR-related gene signature with cell cycle checkpoint function predicts prognosis, immune activity, and chemoradiotherapy response in lung adenocarcinoma. Respiratory Research 23:1.
Crossref
Yanqing Liu & Wei Gu. (2022) The complexity of p53-mediated metabolic regulation in tumor suppression. Seminars in Cancer Biology 85, pages 4-32.
Crossref
Shuang Zhao, Yufei Tang, Ruohan Wang & Masoud Najafi. (2022) Mechanisms of cancer cell death induction by paclitaxel: an updated review. Apoptosis 27:9-10, pages 647-667.
Crossref
Xiaona Wei, Jianping Wu, Jiajia Li & Qiongqiong Yang. (2022) PLK2 targets GSK3β to protect against cisplatin-induced acute kidney injury. Experimental Cell Research 417:1, pages 113181.
Crossref
Chuanyong Zhang, Chuangye Ni & Hao Lu. (2022) Polo-Like Kinase 2: From Principle to Practice. Frontiers in Oncology 12.
Crossref
Pia Pužar Dominkuš, Aner Mesic & Petra Hudler. (2022) PLK2 Single Nucleotide Variant in Gastric Cancer Patients Affects miR-23b-5p Binding . Journal of Gastric Cancer 22:4, pages 348.
Crossref
Ibrahim Diori Karidio & Senay Hamarat Sanlier. (2021) Reviewing cancer’s biology: an eclectic approach. Journal of the Egyptian National Cancer Institute 33:1.
Crossref
Styliani Iliaki, Rudi Beyaert & Inna S. Afonina. (2021) Polo-like kinase 1 (PLK1) signaling in cancer and beyond. Biochemical Pharmacology 193, pages 114747.
Crossref
Noor Rahman, Haroon Khan, Asad Zia, Asifullah Khan, Sajad Fakhri, Michael Aschner, Karim Gul & Luciano Saso. (2021) Bcl-2 Modulation in p53 Signaling Pathway by Flavonoids: A Potential Strategy towards the Treatment of Cancer. International Journal of Molecular Sciences 22:21, pages 11315.
Crossref
Yazhi Fan, Jianming Wang, Na He & Haixiao Feng. (2021) PLK2 protects retinal ganglion cells from oxidative stress by potentiating Nrf2 signaling via GSK‐3β. Journal of Biochemical and Molecular Toxicology 35:8.
Crossref
Monika Kressin, Daniela Fietz, Sven Becker & Klaus Strebhardt. (2021) Modelling the Functions of Polo-Like Kinases in Mice and Their Applications as Cancer Targets with a Special Focus on Ovarian Cancer. Cells 10:5, pages 1176.
Crossref
Theresa A. Kant, Manja Newe, Luise Winter, Maximilian Hoffmann, Susanne Kämmerer, Erik Klapproth, Karolina Künzel, Mark P. Kühnel, Lavinia Neubert, Ali El-Armouche & Stephan R. Künzel. (2021) Genetic Deletion of Polo-Like Kinase 2 Induces a Pro-Fibrotic Pulmonary Phenotype. Cells 10:3, pages 617.
Crossref
Tuyelee Das, Uttpal Anand, Swaroop Kumar Pandey, Charles R. AshbyJrJr, Yehuda G. Assaraf, Zhe-Sheng Chen & Abhijit Dey. (2021) Therapeutic strategies to overcome taxane resistance in cancer. Drug Resistance Updates 55, pages 100754.
Crossref
Christopher A. Raab, Monika Raab, Sven Becker & Klaus Strebhardt. (2021) Non-mitotic functions of polo-like kinases in cancer cells. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1875:1, pages 188467.
Crossref
Jolanta Szenajch, Alicja Szabelska-Beręsewicz, Aleksandra Świercz, Joanna Zyprych-Walczak, Idzi Siatkowski, Michał Góralski, Agnieszka Synowiec & Luiza Handschuh. (2020) Transcriptome Remodeling in Gradual Development of Inverse Resistance between Paclitaxel and Cisplatin in Ovarian Cancer Cells. International Journal of Molecular Sciences 21:23, pages 9218.
Crossref
Chelsea E. Cunningham, Mackenzie J. MacAuley, Frederick S. Vizeacoumar, Omar Abuhussein, Andrew Freywald & Franco J. Vizeacoumar. (2020) The CINs of Polo-Like Kinase 1 in Cancer. Cancers 12:10, pages 2953.
Crossref
Franz Rödel, Shengtao Zhou, Balász Győrffy, Monika Raab, Mourad Sanhaji, Ranadip Mandal, Daniel Martin, Sven Becker & Klaus Strebhardt. (2020) The Prognostic Relevance of the Proliferation Markers Ki-67 and Plk1 in Early-Stage Ovarian Cancer Patients With Serous, Low-Grade Carcinoma Based on mRNA and Protein Expression. Frontiers in Oncology 10.
Crossref
Yu Zeng, Nanhong Li, Wang Liu, Mingqing Zeng, Junfen Cheng & Jian Huang. (2020) Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology 146:10, pages 2447-2460.
Crossref
Shiori Suzuki, Shuichi Tsutsumi, Yu Chen, Chikako Ozeki, Atsushi Okabe, Tatsuya Kawase, Hiroyuki Aburatani & Rieko Ohki. (2020) Identification and characterization of the binding sequences and target genes of p53 lacking the 1st transactivation domain. Cancer Science 111:2, pages 451-466.
Crossref
Amirah Abdul Rahman, Norfilza Mohd Mokhtar, Roslan Harun, Rahman Jamal & Wan Zurinah Wan Ngah. (2019) Transcriptome analysis reveals the molecular mechanisms of combined gamma-tocotrienol and hydroxychavicol in preventing the proliferation of 1321N1, SW1783, and LN18 glioma cancer cells. Journal of Physiology and Biochemistry 75:4, pages 499-517.
Crossref
Aarthi Jayanthan, Bradley Hofmann, Vanessa Meier-Stephenson, Maneka Perinpanayagam, Sandra E. Dunn, Jessica Boklan, Tanya M. Trippett, Tony H. Truong & Aru Narendran. (2019) Targeted Polo-like Kinase Inhibition Combined With Aurora Kinase Inhibition in Pediatric Acute Leukemia Cells. Journal of Pediatric Hematology/Oncology 41:6, pages e359-e370.
Crossref
Min Sung Joo, Sol-Bi Shin, Eun Jung Kim, Hyun Ja Koo, Hyungshin Yim & Sang Geon Kim. (2019) Nrf2‐lncRNA controls cell fate by modulating p53‐dependent Nrf2 activation as an miRNA sponge for Plk2 and p21 cip1 . The FASEB Journal 33:7, pages 7953-7969.
Crossref
Bo Zhou, Steve S Ho, Stephanie U Greer, Noah Spies, John M Bell, Xianglong Zhang, Xiaowei Zhu, Joseph G Arthur, Seunggyu Byeon, Reenal Pattni, Ishan Saha, Yiling Huang, Giltae Song, Dimitri Perrin, Wing H Wong, Hanlee P Ji, Alexej Abyzov & Alexander E Urban. (2019) Haplotype-resolved and integrated genome analysis of the cancer cell line HepG2. Nucleic Acids Research 47:8, pages 3846-3861.
Crossref
Oksana Goroshchuk, Iryna Kolosenko, Linda Vidarsdottir, Alireza Azimi & Caroline Palm-Apergi. (2018) Polo-like kinases and acute leukemia. Oncogene 38:1, pages 1-16.
Crossref
Raquel De Souza, Lais Costa Ayub & Kenneth Yip. 2018. Apoptosis and Beyond. Apoptosis and Beyond 475 510 .
Sabrina Giantulli, Francesca De Iuliis, Ludovica Taglieri, Simone Carradori, Giusi Menichelli, Stefania Morrone, Susanna Scarpa & Ida Silvestri. (2018) Growth arrest and apoptosis induced by kinesin Eg5 inhibitor K858 and by its 1,3,4-thiadiazoline analogue in tumor cells. Anti-Cancer Drugs 29:7, pages 674-681.
Crossref
Yuquan Xie, Ying Liu, Qiubo Li & Jianming Chen. (2018) Polo-like kinase 2 promotes chemoresistance and predicts limited survival benefit from adjuvant chemotherapy in colorectal cancer. International Journal of Oncology.
Crossref
Junko Ohtsuka, Hiroko Oshima, Issei Ezawa, Ryo Abe, Masanobu Oshima & Rieko Ohki. (2018) Functional loss of p53 cooperates with the in vivo microenvironment to promote malignant progression of gastric cancers. Scientific Reports 8:1.
Crossref
Tao Shen, Yan Li, Zhiguang Chen, Shuang Liang, Zhouyang Guo, Ping Wang, Qijun Wu, Gen Ba & Qin Fu. (2017) CHOP negatively regulates Polo-like kinase 2 expression via recruiting C/EBPα to the upstream-promoter in human osteosarcoma cell line during ER stress. The International Journal of Biochemistry & Cell Biology 89, pages 207-215.
Crossref
M Fischer. (2017) Census and evaluation of p53 target genes. Oncogene 36:28, pages 3943-3956.
Crossref
Shanming DengHuilan WangChunling JiaShoukang ZhuXianming ChuQi MaJianqin WeiEmily ChenWei ZhuConrad J. MaconDushyantha T. JayaweeraDerek M. DykxhoornChunming Dong. (2017) MicroRNA-146a Induces Lineage-Negative Bone Marrow Cell Apoptosis and Senescence by Targeting Polo-Like Kinase 2 Expression. Arteriosclerosis, Thrombosis, and Vascular Biology 37:2, pages 280-290.
Crossref
Haiping Liu, Jianye Wang, Lianbing Sheng, Yan Zhang, Ning Tang, Yunfei Li & Tianyu Hao. (2017) Paclitaxel Promotes Cell Apoptosis in Uterine Leiomyomas. Pharmacology 100:5-6, pages 246-252.
Crossref
Arthur ZimmermannArthur Zimmermann. 2017. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract 3245 3261 .
Yael Aylon & Moshe Oren. (2016) The Paradox of p53: What, How, and Why?. Cold Spring Harbor Perspectives in Medicine 6:10, pages a026328.
Crossref
Baochi Ou, Jingkun Zhao, Shaopei Guan, Xiongzhi Wangpu, Congcong Zhu, Yaping Zong, Junjun Ma, Jing Sun, Minhua Zheng, Hao Feng & Aiguo Lu. (2016) Plk2 promotes tumor growth and inhibits apoptosis by targeting Fbxw7/Cyclin E in colorectal cancer. Cancer Letters 380:2, pages 457-466.
Crossref
J. Van den Bossche, F. Lardon, V. Deschoolmeester, I. De Pauw, J.B. Vermorken, P. Specenier, P. Pauwels, M. Peeters & A. Wouters. (2016) Spotlight on Volasertib: Preclinical and Clinical Evaluation of a Promising Plk1 Inhibitor. Medicinal Research Reviews 36:4, pages 749-786.
Crossref
M.V. Ramana Reddy, Balireddy Akula, Shashidhar Jatiani, Rodrigo Vasquez-Del Carpio, Vinay K. Billa, Muralidhar R. Mallireddigari, Stephen C. Cosenza, D.R.C. Venkata Subbaiah, E. Vijaya Bharathi, Venkat R. Pallela, Poornima Ramkumar, Rinku Jain, Aneel K. Aggarwal & E. Premkumar Reddy. (2016) Discovery of 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one (7ao) as a potent selective inhibitor of Polo like kinase 2 (PLK2). Bioorganic & Medicinal Chemistry 24:4, pages 521-544.
Crossref
Sue Haupt, Dinesh Raghu & Ygal Haupt. (2016) Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways. Frontiers in Oncology 6.
Crossref
Arthur ZimmermannArthur Zimmermann. 2016. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract 1 18 .
Zheng Bo Hu, Xiao Hong Liao, Zun Ying Xu, Xiao Yang, Chao Dong, An Min Jin & Hai Lu. (2015) PLK 2 phosphorylates and inhibits enriched TA p73 in human osteosarcoma cells . Cancer Medicine 5:1, pages 74-87.
Crossref
Jung-Eun Park, Tae-Sung Kim, Lingjun Meng, Jeong K. Bang, Bo Y. Kim & Kyung S. Lee. (2015) Putting a bit into the polo-box domain of polo-like kinase 1. Journal of Analytical Science and Technology 6:1.
Crossref
Kyung S. Lee, Terrence R. BurkeJrJr, Jung-Eun Park, Jeong K. Bang & Eunhye Lee. (2015) Recent Advances and New Strategies in Targeting Plk1 for Anticancer Therapy. Trends in Pharmacological Sciences 36:12, pages 858-877.
Crossref
V Archambault, G Lépine & D Kachaner. (2015) Understanding the Polo Kinase machine. Oncogene 34:37, pages 4799-4807.
Crossref
Liang Chen, Farooq Rashid, Abdullah Shah, Hassaan M. Awan, Mingming Wu, An Liu, Jun Wang, Tao Zhu, Zhaofeng Luo & Ge Shan. (2015) The isolation of an RNA aptamer targeting to p53 protein with single amino acid mutation. Proceedings of the National Academy of Sciences 112:32, pages 10002-10007.
Crossref
Tayebeh Oghabi Bakhshaiesh, Marzie Armat, Dariush Shanehbandi, Simin Sharifi, Behzad Baradaran, Mohammad Saeed Hejazi & Nasser Samadi. (2015) Arsenic Trioxide Promotes Paclitaxel Cytotoxicity in Resistant Breast Cancer Cells. Asian Pacific Journal of Cancer Prevention 16:13, pages 5191-5197.
Crossref
Karineh Kazazian, Olga Brashavitskaya, Francis S. W. Zih, David Berger-Richardson, Roland S. Z. Xu, Karina Pacholczyk, Jennifer Macmillan & Carol J. Swallow. (2015) Polo-Like Kinases in Colorectal Cancer: Potential for Targeted Therapy. Current Colorectal Cancer Reports 11:4, pages 187-199.
Crossref
Hila Asraf, Rachel Avunie-Masala, Michal Hershfinkel & Larisa Gheber. (2015) Mitotic Slippage and Expression of Survivin Are Linked to Differential Sensitivity of Human Cancer Cell-Lines to the Kinesin-5 Inhibitor Monastrol. PLOS ONE 10:6, pages e0129255.
Crossref
Xiaoqi Liu. (2015) Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment. Translational Oncology 8:3, pages 185-195.
Crossref
LI YING LIU, WEI WANG, LING YU ZHAO, BO GUO, JUAN YANG, XIAO GE ZHAO, TU SHENG SONG, CHEN HUANG & JI RU XU. (2015) Silencing of polo-like kinase 2 increases cell proliferation and decreases apoptosis in SGC-7901 gastric cancer cells. Molecular Medicine Reports 11:4, pages 3033-3038.
Crossref
Sally-Anne Mortlock, Jerry Wei & Peter Williamson. (2015) T-Cell Activation and Early Gene Response in Dogs. PLOS ONE 10:3, pages e0121169.
Crossref
Ryan T.Y. Wu & Wen-Hsing Cheng. 2015. Foods and Dietary Supplements in the Prevention and Treatment of Disease in Older Adults. Foods and Dietary Supplements in the Prevention and Treatment of Disease in Older Adults 211 229 .
SOMA KUNDU, TAE HYUNG KIM, JUNG HYUN YOON, HAN-SEUNG SHIN, JAEWON LEE, JEE H. JUNG & HYUNG SIK KIM. (2014) Viriditoxin regulates apoptosis and autophagy via mitotic catastrophe and microtubule formation in human prostate cancer cells. International Journal of Oncology 45:6, pages 2331-2340.
Crossref
Yuan Tian, Shuang Fu, Guang-Bin Qiu, Zhen-Ming Xu, Ning Liu, Xiao-Wen Zhang, Sheng Chen, Ye Wang, Kai-Lai Sun & Wei-Neng Fu. (2014) MicroRNA-27a promotes proliferation and suppresses apoptosis by targeting PLK2in laryngeal carcinoma. BMC Cancer 14:1.
Crossref
Wen-Jian Qian, Jung-Eun Park, Dan Lim, Christopher C. Lai, James A. Kelley, Suk-Youl Park, Ki Won Lee, Michael B. Yaffe, Kyung S. Lee & Terrence R. BurkeJr.Jr.. (2014) Mono-anionic phosphopeptides produced by unexpected histidine alkylation exhibit high plk1 polo-box domain-binding affinities and enhanced antiproliferative effects in hela cells. Biopolymers 102:6, pages 444-455.
Crossref
Cinzia Franchin, Luca Cesaro, Lorenzo A. Pinna, Giorgio Arrigoni & Mauro Salvi. (2014) Identification of the PLK2-Dependent Phosphopeptidome by Quantitative Proteomics. PLoS ONE 9:10, pages e111018.
Crossref
Ganipisetti Srinivasrao, Jung-Eun Park, Sungmin Kim, Mija Ahn, Chaejoon Cheong, Ky-Youb Nam, Pethaiah Gunasekaran, Eunha Hwang, Nam-Hyung Kim, Song Yub Shin, Kyung S. Lee, Eunkyung Ryu & Jeong Kyu Bang. (2014) Design and Synthesis of a Cell-Permeable, Drug-Like Small Molecule Inhibitor Targeting the Polo-Box Domain of Polo-Like Kinase 1. PLoS ONE 9:9, pages e107432.
Crossref
LI YING LIU, WEI WANG, LIN YU ZHAO, BO GUO, JUAN YANG, XIAO GE ZHAO, NI HOU, LEI NI, AI YING WANG, TU SHENG SONG, CHEN HUANG & JI RU XU. (2014) miR-126 inhibits growth of SGC-7901 cells by synergistically targeting the oncogenes PI3KR2 and Crk, and the tumor suppressor PLK2. International Journal of Oncology 45:3, pages 1257-1265.
Crossref
Sihem Zitouni, Catarina Nabais, Swadhin Chandra Jana, Adán Guerrero & Mónica Bettencourt-Dias. (2014) Polo-like kinases: structural variations lead to multiple functions. Nature Reviews Molecular Cell Biology 15:7, pages 433-452.
Crossref
Kathryn N. Schaefer & Jacqueline K. Barton. (2014) DNA-Mediated Oxidation of p53. Biochemistry 53:21, pages 3467-3475.
Crossref
Thuy-Ai Nguyen, Daniel Menendez, Michael A. Resnick & Carl W. Anderson. (2014) Mutant TP53 Posttranslational Modifications: Challenges and Opportunities. Human Mutation 35:6, pages 738-755.
Crossref
Su-Yeon Lee, Chuljoon Jang & Kyung-Ah Lee. (2014) Polo-Like Kinases (Plks), a Key Regulator of Cell Cycle and New Potential Target for Cancer Therapy. Development & Reproduciton 18:1, pages 65-71.
Crossref
HE-QI BU, DIAN-LEI LIU, WEI-TIAN WEI, LIANG CHEN, HAI HUANG, YE LI & JUN-HUI CUI. (2014) Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK. Oncology Reports 31:2, pages 975-982.
Crossref
Alejandra Ward & John W. Hudson. (2014) p53-Dependent and Cell Specific Epigenetic Regulation of the Polo-like kinases under Oxidative Stress. PLoS ONE 9:1, pages e87918.
Crossref
Vita Golubovskaya, Baotran Ho, Jeffrey Conroy, Song Liu, Dan Wang & William Cance. (2014) Gene Expression Profiling Identifies Important Genes Affected by R2 Compound Disrupting FAK and P53 Complex. Cancers 6:1, pages 166-178.
Crossref
Jeanette Schwarz, Stefanie Schmidt, Olga Will, Tomas Koudelka, Kaja Köhler, Melanie Boss, Björn Rabe, Andreas Tholey, Jürgen Scheller, Dirk Schmidt-Arras, Michael Schwake, Stefan Rose-John & Athena Chalaris. (2014) Polo-like Kinase 2, a Novel ADAM17 Signaling Component, Regulates Tumor Necrosis Factor α Ectodomain Shedding. Journal of Biological Chemistry 289:5, pages 3080-3093.
Crossref
Raffaela Santoro, Sabrina Strano & Giovanni Blandino. 2014. Mutant p53 and MDM2 in Cancer. Mutant p53 and MDM2 in Cancer 91 103 .
Wen-Jian Qian, Jung-Eun Park, Dan Lim, Suk-Youl Park, Ki-Won Lee, Michael B. Yaffe, Kyung S. Lee & Terrence R. BurkeJr.Jr.. (2013) RETRACTED: Peptide-Based Inhibitors of Plk1 Polo-box Domain Containing Mono-anionic Phosphothreonine Esters and Their Pivaloyloxymethyl Prodrugs. Chemistry & Biology 20:10, pages 1255-1264.
Crossref
Danielle L. Aubele, Roy K. Hom, Marc Adler, Robert A. GalemmoJr.Jr., Simeon Bowers, Anh P. Truong, Hu Pan, Paul Beroza, R. Jeffrey Neitz, Nanhua Yao, May Lin, George Tonn, Heather Zhang, Michael P. Bova, Zhao Ren, Danny Tam, Lany Ruslim, Jeanne Baker, Linnea Diep, Kent Fitzgerald, Jennifer Hoffman, Ruth Motter, Donald Fauss, Pearl Tanaka, Michael Dappen, Jacek Jagodzinski, Wayman Chan, Andrei W. Konradi, Lee Latimer, Yong L. Zhu, Hing L. Sham, John P. Anderson, Marcelle Bergeron & Dean R. Artis. (2013) Selective and Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors That Reduce α-Synuclein Phosphorylation in Rat Brain. ChemMedChem 8:8, pages 1295-1313.
Crossref
Ji Hae Kim, Jung Ok Lee, Soo Kyung Lee, Nami Kim, Ga Young You, Ji Wook Moon, Jie Sha, Su Jin Kim, Sun Hwa Park & Hyeon Soo Kim. (2013) Celastrol suppresses breast cancer MCF-7 cell viability via the AMP-activated protein kinase (AMPK)-induced p53–polo like kinase 2 (PLK-2) pathway. Cellular Signalling 25:4, pages 805-813.
Crossref
Yusuke Mita, Tomomi Noguchi-Yachide, Minoru Ishikawa & Yuichi Hashimoto. (2013) Small-molecular, non-peptide, non-ATP-competitive polo-like kinase 1 (Plk1) inhibitors with a terphenyl skeleton. Bioorganic & Medicinal Chemistry 21:3, pages 608-617.
Crossref
Jen-Yu Hung, Ching-Wen Wen, Ya-Ling Hsu, En-Shyh Lin, Ming-Shyan Huang, Chung-Yi Chen & Po-Lin Kuo. (2013) Subamolide A Induces Mitotic Catastrophe Accompanied by Apoptosis in Human Lung Cancer Cells. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-15.
Crossref
Gang Zhang & Anurag Tandon. (2012) Quantitative assessment on the cloning efficiencies of lentiviral transfer vectors with a unique clone site. Scientific Reports 2:1.
Crossref
Onur Cizmecioglu, Annekatrin Krause, Ramona Bahtz, Lena Ehret, Nisar Malek & Ingrid Hoffmann. (2012) Plk2 regulates centriole duplication through phosphorylation-mediated degradation of Fbxw7 (human Cdc4). Journal of Cell Science 125:4, pages 981-992.
Crossref
Tao Shen, Yan Li, Liqing Yang, Xiaojun Xu, Feng Liang, Shuang Liang, Gen Ba, Feng Xue & Qin Fu. (2012) Upregulation of Polo-like kinase 2 gene expression by GATA-1 acetylation in human osteosarcoma MG-63 cells. The International Journal of Biochemistry & Cell Biology 44:2, pages 423-429.
Crossref
Helen M. Coley, Eleftheria Hatzimichael, Sarah Blagden, Iain McNeish, Alastair Thompson, Tim Crook & Nelofer Syed. (2012) Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in cancer. Oncotarget 3:1, pages 78-83.
Crossref
Geun-Hyoung Ha & Eun-Kyoung Yim Breuer. (2012) Mitotic Kinases and p53 Signaling. Biochemistry Research International 2012, pages 1-14.
Crossref
Paul M. Neilsen, Jacqueline E. Noll, Rachel J. Suetani, Renee B. Schulz, Fares Al-Ejeh, Andreas Evdokiou, David P. Lane & David F. Callen. (2011) Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome. Oncotarget 2:12, pages 1203-1217.
Crossref
Naomi P. Visanji, Sabine Wislet-Gendebien, Loren W. Oschipok, Gang Zhang, Isabelle Aubert, Paul E. Fraser & Anurag Tandon. (2011) Effect of Ser-129 Phosphorylation on Interaction of α-Synuclein with Synaptic and Cellular Membranes. Journal of Biological Chemistry 286:41, pages 35863-35873.
Crossref
A. Kathleen McClendon, Jeffry L. Dean, Adam Ertel, Zhiyan Fu, Dayana B. Rivadeneira, Christopher A. Reed, Ryan J. Bourgo, Agnieszka Witkiewicz, Sankar Addya, Christopher N. Mayhew, H. Leighton Grimes, Paolo Fortina & Erik S. Knudsen. (2011) RB and p53 Cooperate to Prevent Liver Tumorigenesis in Response to Tissue Damage. Gastroenterology 141:4, pages 1439-1450.
Crossref
Fa Liu, Jung-Eun Park, Wen-Jian Qian, Dan Lim, Martin Gräber, Thorsten Berg, Michael B Yaffe, Kyung S Lee & Terrence R BurkeJrJr. (2011) Serendipitous alkylation of a Plk1 ligand uncovers a new binding channel. Nature Chemical Biology 7:9, pages 595-601.
Crossref
Leonidas Benetatos, Aggeliki Dasoula, Eleftheria Hatzimichael, Nelofer Syed, Maria Voukelatou, George Dranitsaris, Konstantinos L. Bourantas & Tim Crook. (2011) Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions. Annals of Hematology 90:9, pages 1037-1045.
Crossref
El Mustapha Bahassi. (2011) Polo-like kinases and DNA damage checkpoint: beyond the traditional mitotic functions. Experimental Biology and Medicine 236:6, pages 648-657.
Crossref
Nelofer Syed, Helen M. Coley, Jalid Sehouli, Dominique Koensgen, Alexander Mustea, Peter Szlosarek, Iain McNeish, Sarah P. Blagden, Peter Schmid, David P. Lovell, Eleftheria Hatzimichael & Tim Crook. (2011) Polo-like Kinase Plk2 Is an Epigenetic Determinant of Chemosensitivity and Clinical Outcomes in Ovarian Cancer. Cancer Research 71:9, pages 3317-3327.
Crossref
Mykyta V. Sokolov, Irina V. Panyutin, Igor G. Panyutin & Ronald D. Neumann. (2011) Dynamics of the transcriptome response of cultured human embryonic stem cells to ionizing radiation exposure. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 709-710, pages 40-48.
Crossref
Ashley M. Ramirez-Herrick, Shannon E. Mullican, Andrea M. Sheehan & Orla M. Conneely. (2011) Reduced NR4A gene dosage leads to mixed myelodysplastic/myeloproliferative neoplasms in mice. Blood 117:9, pages 2681-2690.
Crossref
Meghna U. Naik, Ngoc T. Pham, Kristin Beebe, Wei Dai & Ulhas P. Naik. (2011) Calcium-dependent inhibition of polo-like kinase 3 activity by CIB1 in breast cancer cells. International Journal of Cancer 128:3, pages 587-596.
Crossref
Pankaj Taneja, Sinan Zhu, Dejan Maglic, Eizabeth A. Fry, Robert D. Kendig & Kazushi Inoue. (2011) Transgenic and Knockout Mice Models to Reveal the Functions of Tumor Suppressor Genes. Clinical Medicine Insights: Oncology 5, pages CMO.S7516.
Crossref
Susanne M. A. Lens, Emile E. Voest & René H. Medema. (2010) Shared and separate functions of polo-like kinases and aurora kinases in cancer. Nature Reviews Cancer 10:12, pages 825-841.
Crossref
Klaus Strebhardt. (2010) Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy. Nature Reviews Drug Discovery 9:8, pages 643-660.
Crossref
Y Niikura, H Ogi, K Kikuchi & K Kitagawa. (2010) BUB3 that dissociates from BUB1 activates caspase-independent mitotic death (CIMD). Cell Death & Differentiation 17:6, pages 1011-1024.
Crossref
Jung-Eun Park, Nak-Kyun Soung, Yoshikazu Johmura, Young H. Kang, Chenzhong Liao, Kyung H. Lee, Chi Hoon Park, Marc C. Nicklaus & Kyung S. Lee. (2010) Polo-box domain: a versatile mediator of polo-like kinase function. Cellular and Molecular Life Sciences 67:12, pages 1957-1970.
Crossref
Yan Degenhardt & Thomas Lampkin. (2010) Targeting Polo-like Kinase in Cancer Therapy. Clinical Cancer Research 16:2, pages 384-389.
Crossref
Xu-Fang Duan, Ying-Li Wu, Han-Zhang Xu, Meng Zhao, Han-Yi Zhuang, Xiao-Dong Wang, Hua Yan & Guo-Qiang Chen. (2010) Synergistic mitosis-arresting effects of arsenic trioxide and paclitaxel on human malignant lymphocytes. Chemico-Biological Interactions 183:1, pages 222-230.
Crossref
Jay F. Dorsey, Akiva Mintz, Xiaobing Tian, Melissa L. Dowling, John P. Plastaras, David T. Dicker, Gary D. Kao & Wafik S. El-Deiry. (2009) Tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells . Molecular Cancer Therapeutics 8:12, pages 3285-3295.
Crossref
Melissa G. Ooi, Patrick J. Hayden, Vassiliki Kotoula, Douglas W. McMillin, Elpida Charalambous, Emily Daskalaki, Noopur S. Raje, Nikhil C. Munshi, Dharminder Chauhan, Teru Hideshima, Leutz Buon, Martin Clynes, Peter O'Gorman, Paul G. Richardson, Constantine S. Mitsiades, Kenneth C. Anderson & Nicholas Mitsiades. (2009) Interactions of the Hdm2/p53 and Proteasome Pathways May Enhance the Antitumor Activity of Bortezomib. Clinical Cancer Research 15:23, pages 7153-7160.
Crossref
Emeline de Viron, Laurent Knoops, Thierry Connerotte, Caroline Smal, Lucienne Michaux, Pascale Saussoy, Pascal Vannuffel, Eline Beert, Marie-Christiane Vekemans, C��dric Hermans, Fran��oise Bontemps & Eric Van Den Neste. (2009) Impaired up-regulation of polo-like kinase 2 in B-cell chronic lymphocytic leukaemia lymphocytes resistant to fludarabine and 2-chlorodeoxyadenosine: a potential marker of defective damage response. British Journal of Haematology 147:5, pages 641-652.
Crossref
Wolfgang Reindl, Martin Gräber, Klaus Strebhardt & Thorsten Berg. (2009) Development of high-throughput assays based on fluorescence polarization for inhibitors of the polo-box domains of polo-like kinases 2 and 3. Analytical Biochemistry 395:2, pages 189-194.
Crossref
Takumi Matsumoto, Ping-yuan Wang, Wenzhe Ma, Ho Joong Sung, Satoaki Matoba & Paul M. Hwang. (2009) Polo-like kinases mediate cell survival in mitochondrial dysfunction. Proceedings of the National Academy of Sciences 106:34, pages 14542-14546.
Crossref
Bei Wang, Ziwei Xiao & Ee Chee Ren. (2009) Redefining the p53 response element. Proceedings of the National Academy of Sciences 106:34, pages 14373-14378.
Crossref
Sang-Moon Yun, Tinoush Moulaei, Dan Lim, Jeong K Bang, Jung-Eun Park, Shilpa R Shenoy, Fa Liu, Young H Kang, Chenzhong Liao, Nak-Kyun Soung, Sunhee Lee, Do-Young Yoon, Yoongho Lim, Dong-Hee Lee, Akira Otaka, Ettore Appella, James B McMahon, Marc C Nicklaus, Terrence R Burke Jr, Michael B Yaffe, Alexander Wlodawer & Kyung S Lee. (2009) Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1. Nature Structural & Molecular Biology 16:8, pages 876-882.
Crossref
Wolfgang Reindl, Juping Yuan, Andrea Krämer, Klaus Strebhardt  & Thorsten Berg. (2009) A Pan-Specific Inhibitor of the Polo-Box Domains of Polo-like Kinases Arrests Cancer Cells in Mitosis. ChemBioChem 10:7, pages 1145-1148.
Crossref
Dorothea Rudolph, Martin Steegmaier, Matthias Hoffmann, Matthias Grauert, Anke Baum, Jens Quant, Christian Haslinger, Pilar Garin-Chesa & Günther R. Adolf. (2009) BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity. Clinical Cancer Research 15:9, pages 3094-3102.
Crossref
Berit R. Høj, Jonas M. la Cour, Jens Mollerup & Martin W. Berchtold. (2009) ALG-2 knockdown in HeLa cells results in G2/M cell cycle phase accumulation and cell death. Biochemical and Biophysical Research Communications 378:1, pages 145-148.
Crossref
Katsumi Kitagawa. 2009. Essentials of Apoptosis. Essentials of Apoptosis 635 646 .
Zejuan LiJun LuMiao SunShuangli MiHao ZhangRoger T. LuoPing ChenYungui WangMing Yan, Zhijian QianMary Beth NeillyJie JinYanming ZhangStefan K. Bohlander, Dong-Er ZhangRichard A. LarsonMichelle M. Le BeauMichael J. ThirmanTodd R. Golub, Janet D. RowleyJianjun Chen. (2008) Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proceedings of the National Academy of Sciences 105:40, pages 15535-15540.
Crossref
Pei-Chen Hsu, Hui-Chih Hung, Ya-Fan Liao, Chu-Chen Liu, Gregory J. Tsay & Guang-Yaw Liu. (2008) Ornithine decarboxylase attenuates leukemic chemotherapy drugs-induced cell apoptosis and arrest in human promyelocytic HL-60 cells. Leukemia Research 32:10, pages 1530-1540.
Crossref
Valentina Zuco & Franco Zunino. (2008) Cyclic Pifithrin-α Sensitizes Wild Type p53 Tumor Cells to Antimicrotubule Agent–Induced Apoptosis. Neoplasia 10:6, pages 587-596.
Crossref
R U Jänicke, D Sohn & K Schulze-Osthoff. (2008) The dark side of a tumor suppressor: anti-apoptotic p53. Cell Death & Differentiation 15:6, pages 959-976.
Crossref
Barbara C.M. van de Weerdt, Dene R. Littler, Rob Klompmaker, Angelina Huseinovic, Alex Fish, Anastassis Perrakis & René H. Medema. (2008) Polo-box domains confer target specificity to the Polo-like kinase family. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1783:6, pages 1015-1022.
Crossref
Todd Riley, Eduardo Sontag, Patricia Chen & Arnold Levine. (2008) Transcriptional control of human p53-regulated genes. Nature Reviews Molecular Cell Biology 9:5, pages 402-412.
Crossref
A. Jo Chien & Mark M. Moasser. (2008) Cellular Mechanisms of Resistance to Anthracyclines and Taxanes in Cancer: Intrinsic and Acquired. Seminars in Oncology 35, pages S1-S14.
Crossref
Jernej Kristl, Petra Slanc, Metka Krašna, Aleš Berlec, Matjaž Jeras & Borut Štrukelj. (2007) Calcipotriol Affects Keratinocyte Proliferation by Decreasing Expression of Early Growth Response-1 and Polo-like Kinase-2. Pharmaceutical Research 25:3, pages 521-529.
Crossref
Roya Khosravi-Far & Eileen WhiteKageaki Kuribayashi & Wafik S. El-Deiry. 2008. Programmed Cell Death in Cancer Progression and Therapy. Programmed Cell Death in Cancer Progression and Therapy 201 221 .
Jennifer Sekowski & James Dillman Iii. 2007. Chemical Warfare Agents. Chemical Warfare Agents.
Christopher Brynczka, Paul Labhart & B Alex Merrick. (2007) NGF-mediated transcriptional targets of p53 in PC12 neuronal differentiation. BMC Genomics 8:1.
Crossref
Michael Kothe, Darcy Kohls, Simon Low, Rocco Coli, Glen R. Rennie, Frederic Feru, Cyrille Kuhn & Yuan-Hua Ding. (2007) Selectivity-determining Residues in Plk1. Chemical Biology & Drug Design 70:6, pages 540-546.
Crossref
Guang-Yong Li, Hye-Young Lee, Ho-Sang Shin, Hyeon-Young Kim, Cheol-Hong Lim & Byung-Hoon Lee. (2007) Identification of Gene Markers for Formaldehyde Exposure in Humans. Environmental Health Perspectives 115:10, pages 1460-1466.
Crossref
Yun-Yong Park, Seok-Ho Kim, Yong Joo Kim, Sun Yee Kim, Tae-Hoon Lee, In-Kyu Lee, Seung Bum Park & Hueng-Sik Choi. (2007) RETRACTED: Polo-like kinase 2 gene expression is regulated by the orphan nuclear receptor estrogen receptor-related receptor gamma (ERRγ). Biochemical and Biophysical Research Communications 362:1, pages 107-113.
Crossref
Eric F. Johnson, Kent D. Stewart, Keith W. Woods, Vincent L. Giranda & Yan Luo. (2007) Pharmacological and Functional Comparison of the Polo-like Kinase Family:  Insight into Inhibitor and Substrate Specificity. Biochemistry 46:33, pages 9551-9563.
Crossref
Yohei Niikura, Amruta Dixit, Ray Scott, Guy Perkins & Katsumi Kitagawa. (2007) BUB1 mediation of caspase-independent mitotic death determines cell fate. The Journal of Cell Biology 178:2, pages 283-296.
Crossref
Travis L. Schmit & Nihal Ahmad. (2007) Regulation of mitosis via mitotic kinases: new opportunities for cancer management. Molecular Cancer Therapeutics 6:7, pages 1920-1931.
Crossref
Cristiana Lo Nigro, Elena Arnolfo, Enrico Taricco, Adriana Fruttero, Elvio Grazioso Russi, Francesco Lucio, Silvana Ribero, Alberto Comino, Marco Merlano & Silvana Ungari. (2007) The cisplatin–irradiation combination suggests that apoptosis is not a major determinant of clonogenic death. Anti-Cancer Drugs 18:6, pages 659-667.
Crossref
Meike Eickhoff, Jessica Thalmann, Simone Hess, Myriam Martin, Thomas Laue, Joachim Kruppa, Gudrun Brandes & Andreas Klos. (2007) Host Cell Responses to Chlamydia pneumoniae in Gamma Interferon-Induced Persistence Overlap Those of Productive Infection and Are Linked to Genes Involved in Apoptosis, Cell Cycle, and Metabolism . Infection and Immunity 75:6, pages 2853-2863.
Crossref
Lindsey A. Allan & Paul R. Clarke. (2007) Phosphorylation of Caspase-9 by CDK1/Cyclin B1 Protects Mitotic Cells against Apoptosis. Molecular Cell 26:2, pages 301-310.
Crossref
Kun-Xian Shu, Biao Li & Li-Xiang Wu. (2007) The p53 network: p53 and its downstream genes. Colloids and Surfaces B: Biointerfaces 55:1, pages 10-18.
Crossref
Takashi Watanabe, Kaori Tobe, Yutaka Nakachi, Yasumitsu Kondoh, Madoka Nakajima, Shuichi Hamada, Chiaki Namiki, Takayoshi Suzuki, Satoru Maeda, Ayami Tadakuma, Mikiya Sakurai, Yuko Arai, Atsushi Hyogo, Masako Hoshino, Tomoko Tashiro, Hisashi Ito, Hiroshige Inazumi, Yoshiyuki Sakaki, Hideo Tashiro & Chie Furihata. (2007) Differential Gene Expression Induced by Two Genotoxic N-nitroso Carcinogens, Phenobarbital and Ethanol in Mouse Liver Examined with Oligonucleotide Microarray and Quantitative Real-time PCR. Genes and Environment 29:3, pages 115-127.
Crossref
Maria Leao, Emma Anderton, Mark Wade, Kiran Meekings & Martin J. Allday. (2007) Epstein-Barr Virus-Induced Resistance to Drugs That Activate the Mitotic Spindle Assembly Checkpoint in Burkitt's Lymphoma Cells. Journal of Virology 81:1, pages 248-260.
Crossref
Annette K. Larsen, DVM PhD, Andrzej Skladanowski & PhD DSc. 2007. Apoptosis, Senescence, and Cancer. Apoptosis, Senescence, and Cancer 407 422 .
O. P. Kisurina-Evgen’eva, S. A. Bryantseva, A. A. Shtil’ & G. E. Onishchenko. (2006) Antitubulin agents can initiate different apoptotic pathways. Biophysics 51:5, pages 771-775.
Crossref
Shulin Wang & Wafik S. El-Deiry. (2006) p73 or p53 Directly Regulates Human p53 Transcription to Maintain Cell Cycle Checkpoints . Cancer Research 66:14, pages 6982-6989.
Crossref
Justin Stebbing, Mark Bower, Nelofer SyedPaul SmithVeronica Yu & Tim Crook. (2006) Epigenetics: an emerging technology in the diagnosis and treatment of cancer. Pharmacogenomics 7:5, pages 747-757.
Crossref
Tong Zhou, Jeff W. Chou, Dennis A. Simpson, Yingchun Zhou, Thomas E. Mullen, Margarida Medeiros, Pierre R. Bushel, Richard S. Paules, Xuebin Yang, Patrick Hurban, Edward K. Lobenhofer & William K. Kaufmann. (2006) Profiles of Global Gene Expression in Ionizing-Radiation–Damaged Human Diploid Fibroblasts Reveal Synchronization behind the G 1 Checkpoint in a G 0 -like State of Quiescence . Environmental Health Perspectives 114:4, pages 553-559.
Crossref
Anne-Jan Dijkhuis, Karin Klappe, Susan Jacobs, Bart-Jan Kroesen, Willem Kamps, Hannie Sietsma & Jan Willem Kok. (2006) PDMP sensitizes neuroblastoma to paclitaxel by inducing aberrant cell cycle progression leading to hyperploidy. Molecular Cancer Therapeutics 5:3, pages 593-601.
Crossref
Mandar R. Bhonde, Marie-Luise Hanski, Jan Budczies, Minh Cao, Bernd Gillissen, Dhatchana Moorthy, Federico Simonetta, Hans Scherübl, Matthias Truss, Christian Hagemeier, Hans-Werner Mewes, Peter T. Daniel, Martin Zeitz & Christoph Hanski. (2006) DNA Damage-induced Expression of p53 Suppresses Mitotic Checkpoint Kinase hMps1. Journal of Biological Chemistry 281:13, pages 8675-8685.
Crossref
Masaki Ueno, Kei-ichi Katayama, Hirofumi Yamauchi, Hiroyuki Nakayama & Kunio Doi. (2006) Cell cycle and cell death regulation of neural progenitor cells in the 5-azacytidine (5AzC)-treated developing fetal brain. Experimental Neurology 198:1, pages 154-166.
Crossref
Nelofer Syed, Paul Smith, Alexandra Sullivan, Lindsay C. Spender, Martin Dyer, Lorraine Karran, Jenny O'Nions, Martin Allday, Ingrid Hoffmann, Dorothy Crawford, Beverley Griffin, Paul J. Farrell & Tim Crook. (2006) Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies . Blood 107:1, pages 250-256.
Crossref
Déborah Zyss, Philippe Montcourrier, Benjamin Vidal, Christelle Anguille, Fabrice Mérezègue, Alain Sahuquet, Paul H. Mangeat & Peter J. Coopman. (2005) The Syk Tyrosine Kinase Localizes to the Centrosomes and Negatively Affects Mitotic Progression. Cancer Research 65:23, pages 10872-10880.
Crossref
Shannon Reagan-Shaw & Nihal Ahmad. (2005) Polo-like kinase (Plk) 1 as a target for prostate cancer management. IUBMB Life (International Union of Biochemistry and Molecular Biology: Life) 57:10, pages 677-682.
Crossref
Yuchi Hirose, Makoto Katayama, Olga K. Mirzoeva, Mitchel S. Berger & Russell O. Pieper. (2005) Akt Activation Suppresses Chk2-Mediated, Methylating Agent–Induced G2 Arrest and Protects from Temozolomide-Induced Mitotic Catastrophe and Cellular Senescence. Cancer Research 65:11, pages 4861-4869.
Crossref
Masakazu Muramoto, Takao Yamazaki, Noriyuki Morikawa, Osamu Okitsu, Takeyuki Nagashima, Tomoya Oe, Shintaro Nishimura & Yasuhiro Kita. (2005) Protective effect of FK506 against apoptosis of SH-SY5Y cells correlates with regulation of the serum inducible kinase gene. Biochemical Pharmacology 69:10, pages 1473-1481.
Crossref
Jun Li, Mingjia Tan, Ling Li, Deepika Pamarthy, Theodore S. Lawrence & Yi Sun. (2005) SAK, A New Polo-Like Kinase, Is Transcriptionally Repressed by p53 and Induces Apoptosis upon RNAi Silencing. Neoplasia 7:4, pages 312-323.
Crossref
R Li, T Moudgil, H J Ross & H -M Hu. (2005) Apoptosis of non-small-cell lung cancer cell lines after paclitaxel treatment involves the BH3-only proapoptotic protein Bim. Cell Death & Differentiation 12:3, pages 292-303.
Crossref
Drew M Lowery, Daniel Lim & Michael B Yaffe. (2005) Structure and function of Polo-like kinases. Oncogene 24:2, pages 248-259.
Crossref
Frank Eckerdt, Juping Yuan & Klaus Strebhardt. (2005) Polo-like kinases and oncogenesis. Oncogene 24:2, pages 267-276.
Crossref
Jeffrey A Winkles & Gregory F Alberts. (2005) Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues. Oncogene 24:2, pages 260-266.
Crossref
Suqing Xie, Bin Xie, Marietta Y Lee & Wei Dai. (2005) Regulation of cell cycle checkpoints by polo-like kinases. Oncogene 24:2, pages 277-286.
Crossref
Yuval Tabach, Michael Milyavsky, Igor Shats, Ran Brosh, Or Zuk, Assif Yitzhaky, Roberto Mantovani, Eytan Domany, Varda Rotter & Yitzhak Pilpel. (2005) The promoters of human cell cycle genes integrate signals from two tumor suppressive pathways during cellular transformation. Molecular Systems Biology 1:1.
Crossref
James F. Dillman, Christopher S. Phillips, Linda M. Dorsch, Matthew D. Croxton, Alison I. Hege, Albert J. Sylvester, Theodore S. Moran & Alfred M. Sciuto. (2004) Genomic Analysis of Rodent Pulmonary Tissue Following Bis-(2-chloroethyl) Sulfide Exposure. Chemical Research in Toxicology 18:1, pages 28-34.
Crossref
Timothy MacLachlan & Wafik El-Deiry. 2005. The p53 Tumor Suppressor Pathway and Cancer. The p53 Tumor Suppressor Pathway and Cancer 53 80 .
Conly L. Rieder & Helder Maiato. (2004) Stuck in Division or Passing through. Developmental Cell 7:5, pages 637-651.
Crossref
Hitoshi Okada & Tak W. Mak. (2004) Pathways of apoptotic and non-apoptotic death in tumour cells. Nature Reviews Cancer 4:8, pages 592-603.
Crossref
Silke Warnke, Stefan Kemmler, Rebecca S Hames, Hsiao-Lun Tsai, Urs Hoffmann-Rohrer, Andrew M Fry & Ingrid Hoffmann. (2004) Polo-like Kinase-2 Is Required for Centriole Duplication in Mammalian Cells. Current Biology 14:13, pages 1200-1207.
Crossref
Francis A. Barr, Herman H. W. Silljé & Erich A. Nigg. (2004) Polo-like kinases and the orchestration of cell division. Nature Reviews Molecular Cell Biology 5:6, pages 429-441.
Crossref
Maria Castedo, Jean-Luc Perfettini, Thomas Roumier, Alexander Valent, Hana Raslova, Kenichi Yakushijin, David Horne, Jean Feunteun, Gilbert Lenoir, René Medema, William Vainchenker & Guido Kroemer. (2004) Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy. Oncogene 23:25, pages 4362-4370.
Crossref
Maria Castedo, Jean-Luc Perfettini, Thomas Roumier, Karine Andreau, Rene Medema & Guido Kroemer. (2004) Cell death by mitotic catastrophe: a molecular definition. Oncogene 23:16, pages 2825-2837.
Crossref
Tao Li, Chun-Yun Chang, Da-Yun Jin, Pen-Jen Lin, Anastasia Khvorova & Darrel W. Stafford. (2004) Identification of the gene for vitamin K epoxide reductase. Nature 427:6974, pages 541-544.
Crossref
Milena Gasco & Tim Crook. (2003) p53 family members and chemoresistance in cancer: what we know and what we need to know. Drug Resistance Updates 6:6, pages 323-328.
Crossref
Wafik S El-Deiry. (2003) The role of p53 in chemosensitivity and radiosensitivity. Oncogene 22:47, pages 7486-7495.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.